Preprint Communication Version 1 Preserved in Portico This version is not peer-reviewed

Analysis of Tianeptine in Dietary Supplements

Version 1 : Received: 4 July 2023 / Approved: 5 July 2023 / Online: 5 July 2023 (13:04:28 CEST)

A peer-reviewed article of this Preprint also exists.

Seale, J.T.; Garden, E.A.; French, J.M.T.; McDougal, O.M. Analysis of Tianeptine in Dietary Supplements. Nutraceuticals 2023, 3, 481-488. Seale, J.T.; Garden, E.A.; French, J.M.T.; McDougal, O.M. Analysis of Tianeptine in Dietary Supplements. Nutraceuticals 2023, 3, 481-488.

Abstract

In the United States (US), tianeptine is sold as a dietary supplement under the trade name Tianaa™. Tianeptine is a synthetic drug prescribed by physicians as an antidepressant in parts of Europe, Asia and South America. The drug is not permitted for use by physicians in the US, be-cause it is a μ-opioid receptor agonist with a propensity for severe addiction. As incidence of Tianaa™ related opioid addiction across the southern US escalate, the current study aimed to quantify tianeptine in over the counter Tianaa™ White, Red, and Green products. The results of this investigation measured tianeptine levels between 3.1 to 10.9 mg per 531 mg capsules. Tianaa™ White capsules consistently contained the least tianeptine, while Green had the most. Close inspection of Tianaa™ products showed that capsule mass varied by as much as 16% from label claim, and the amount of tianeptine per capsule varied by as much as 35 % from the aver-age measured amount for each product. Tianaa™ Red contains kava leaf extract, which led to the identification of four kavapyrone components by mass spectrometry. The data presented pro-vide insight into tianeptine quantity and capsule mass variation for Tianaa™ supplements sold to customers naive to the risk of addiction.

Keywords

Dietary supplement, μ-opioid-receptor agonist, addiction, antidepressant

Subject

Medicine and Pharmacology, Pharmacology and Toxicology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.